Big Gain For Clovis Oncology, Inc.

Fri, Jun 17, 2022 at 05:33 PM
Big Gain For Clovis Oncology, Inc.

Clovis Oncology, Inc. (CLVS:NASDAQ) rocketted at $1.18, representing a gain of 31.9%. The stock got featured on our News Catalysts scanner on Thu, Jun 16, 2022 at 07:32 PM in the 'BIOTECH' category. From Thu, Jun 02, 2022, the stock recorded 60.00% Up Days and 45.45% Green Days

The stock spiked on Tue, Jun 14, 2022 at $1.12 with a volume of 64M+.

About Clovis Oncology, Inc. (CLVS:NASDAQ)

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.